| 000 | 01747cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030922.0 | ||
| 008 | 140104s2013 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.18.Ph.D.2013.Ah.U | ||
| 100 | 0 | _aAhmed Mohammed Abdelhamid Soliman | |
| 245 | 1 | 0 |
_aUrine osteoprotegerin as a biomarker in lupus nephritis / _cAhmed Mohammed Abdelhamid Soliman ; Supervised Omar Yehia Elkhashab , Mohamed Mostafa Elkhateeb , Amaal Abdou Abdelaal |
| 246 | 1 | 5 | _aمادة اوستيوبروتيوجيرين فى البول كدلالة التهابات الكلى فى مرضى الذئبة الحمراء |
| 260 |
_aCairo : _bAhmed Mohammed Abdelhamid Soliman , _c2013 |
||
| 300 |
_a136 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aLupus nephritis occurs in over 50% of patients with systemic lupus erythematosis (SLE) . Reports of 5- year renal survival with treatment ranges from 46 to 95% . Early diagnosis and prompt treatment however may significantly improve the long - term prognosis . Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aLupus nephritis | |
| 653 | 4 | _aSystemic lupus erythematosis | |
| 653 | 4 | _aUrine OPG | |
| 700 | 0 |
_aAmaal Abdou Abdelaal , _eSupervisor |
|
| 700 | 0 |
_aMohamed Mostafa Elkhateeb , _eSupervisor |
|
| 700 | 0 |
_aOmar Yehia Elkhashab , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44714 _d44714 |
||